GlassScriptPhysician profile
Fariha Atmar
NPI 1891710661
$1,520.25
in general payments reported to CMS, 2019-2025
20 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.29 · 2022: $120 · 2023: $223 · 2024: $543 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $301.51 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $195.25 | 2021-2025 | |
| Novo Nordisk INC | $189.53 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Gilead Sciences, INC. | $135.25 | 2024-2025 | Epclusa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.92 | 2021-2023 | Spiriva Respimat |
| Exact Sciences Corporation | $96.48 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Medtronic, INC. | $92.83 | 2022-2025 | Minimed 780g |
| Pfizer INC. | $66.85 | 2021-2025 | |
| Glaxosmithkline, LLC. | $55.45 | 2024-2025 | Bexsero |
| Dexcom, INC. | $47.23 | 2024-2025 | Dexcom G6 Transmitter |
| Cranial Technologies, INC | $44.29 | 2021-2024 | Doc Band |
| Verona Pharma, INC. | $27.42 | 2025 | Ohtuvayre |
| Sanofi Pasteur INC. | $26.14 | 2024 | |
| Ani Pharmaceuticals, INC. | $25.25 | 2025 | Purified Cortrophin Gel |
| Hologic Sales and Service, LLC | $24.51 | 2025 | Aptima |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $19.86 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $19.44 | 2025 | Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.04 | 2025 | Xifaxan |
| Xeris Pharmaceuticals, INC. | $15.19 | 2023 | Gvoke Hypopen |
| Cequr Corporation | $6.81 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fariha Atmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.